Dépêches

Sparton Corporation to Highlight Expanded Operations and Capabilities at MD&M West 2011

Dépèche transmise le 1 février 2011 par Business Wire

Sparton Corporation to Highlight Expanded Operations and Capabilities at MD&M West 2011

SCHAUMBURG, Ill.--(BUSINESS WIRE)--(Booth #2105) - Sparton Corporation (NYSE: SPA), a supplier of complex and reliable electronic and electro-mechanical products, sub-assemblies and related services to the highly regulated Medical, Defense & Security and Aerospace markets, today announced it will launch its expanded operations and capabilities at the Medical Design & Manufacturing West (MD&M) conference and exhibition February 8-10, 2011, at the Anaheim Convention Center.

“In addition to introducing our comprehensive suite of medical services during the MD&M show, we are unveiling our new brand, look and marketing/communication platform that will better articulate the outstanding levels of expertise, knowledge and service we make available to our medical device clients.”

With the integration of Delphi Medical Systems of Frederick, Colorado complete, Sparton now offers the most comprehensive medical manufacturing and systems integration capabilities of class II and class III complex therapeutic, diagnostic, and surgical devices, as well as providing engineering support in applied technologies such as fluidics, optics, lasers, software, user interfaces, and radio frequency (RF). With this acquisition, the company also broadens its geographic coverage to the West coast to complement its manufacturing and engineering footprints already located in Ohio, Florida and Vietnam.

“The acquisition of Delphi Medical is consistent with our strategy to strengthen our leadership position in the contract manufacturing medical device market, in particular expanding into therapeutic devices to complement the expertise and market leading position we already have in the In Vitro Diagnostics space," said Cary Wood, President & CEO of Sparton Corporation. "This acquisition is a natural extension of our industry-leading internal bio-hazard testing and medical engineering capabilities which provide clients a global manufacturing presence coupled with related design, development, rapid prototyping, manufacturing and delivery services and solutions via our facilities in the U.S. and Asia. Future acquisitions will provide additional services enabling us to provide an even more comprehensive end-to-end medical device solution for our customers.”

Highlights of Sparton’s end-to-end product development solutions and current capabilities include:

• Enhanced Quality Programs Exceeding FDA Requirements
• Precision Fluidic and Robotic Handling Systems
• Thermally Controlled Systems
• Lasers and Optics
• Class 10,000, 1,000, & 100 Clean Room Environments
• Embedded Systems
• Electronics Modules/Sensor Design
• User Interface Development
• Systems Integration & Engineering
• Immunochemistry
• DFx Analysis & Obsolescence Management

Sparton also offers a valuable rapid prototyping service called Sparton Express. This unique system offers the means for manufacturing and testing multiple aspects of a client’s existing or newly designed electronic assemblies prior to production release and can also facilitate a cost effective way to manufacture lower volume end-of-life products.

“Sparton is committed to the medical device industry,” added Mr. Wood. “In addition to introducing our comprehensive suite of medical services during the MD&M show, we are unveiling our new brand, look and marketing/communication platform that will better articulate the outstanding levels of expertise, knowledge and service we make available to our medical device clients.”

About Sparton Corporation

Sparton Corporation (NYSE:SPA), now in its 111th year, is a provider of complex and sophisticated electromechanical devices with capabilities that include concept development, industrial design, design and manufacturing engineering, production, distribution, and field service. The primary markets served are in the Medical Device, Defense & Security Systems, Navigation & Exploration and Complex Systems Manufacturing industries.

Sparton Corporation is headquartered in Schaumburg, IL. The company’s medical engineering facilities are located in Frederick, Colorado and Strongsville, Ohio, as well as in Vietnam. For more information, interested parties may contact Mike Osborne at (847) 762-5814 or [email protected] or visit the company’s Web site at http://www.sparton.com.

Safe Harbor and Fair Disclosure Statement

Certain statements described in this press release are forward-looking statements within the scope of the Securities Act of 1933, as amended (the “Securities Act”), and the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements may be identified by the words “believe,” “expect,” “anticipate,” “project,” “plan,” “estimate,” “will” or “intend” and similar words or expressions. These forward-looking statements reflect Sparton’s current views with respect to future events and are based on currently available financial, economic and competitive data and its current business plans. Actual results could vary materially depending on risks and uncertainties that may affect Sparton’s operations, markets, prices and other factors. Important factors that could cause actual results to differ materially from those forward-looking statements include, but are not limited to, Sparton’s financial performance and the implementations and results of its ongoing strategic initiatives. For a more detailed discussion of these and other risk factors, see Part I, Item 1A, Risk Factors and Part II, Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in Sparton’s Form 10-K for the year ended June 30, 2009, and its other filings with the Securities and Exchange Commission. Sparton undertakes no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.